ArticleBMC medical informatics and decision making2020
Availability, price, and affordability of WHO priority maternal and child health medicine in public health facilities of Dessie, north-East Ethiopia.
Article in BMC medical informatics and decision making, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Availability of essential medicines in conflict-affected african regions: a systematic review and meta-analysis.Conflict and health · 2026Review
- Inventory Management Performance for Lifesaving Maternal and Child Health Medicines in Amhara Regional State, Ethiopia: A Facility-Based Cross-Sectional Mixed Method Study.Health science reports · 2026Article
- Determinants, Models, performances, and strategies of supply chain to address medicine stockouts in primary health care: a scoping review.Journal of pharmaceutical policy and practice · 2026Review
- The triple burden: A systematic review and meta-analysis of essential medicine availability, price, and affordability across Ethiopian health facilities.Exploratory research in clinical and social pharmacy · 2025Review
- Assessment of availability and challenges of WHO recommended priority life-saving medicines for under five-year children in primary public health facilities of Amhara region.BMC pediatrics · 2023Article
- Article
- Impact of COVID-19 pandemic on the availability of maternal and child health products and childhood vaccines.Journal of pharmaceutical policy and practice · 2023Article
- Availability and affordability of priority lifesaving maternal health medicines in Addis Ababa, Ethiopia.BMC health services research · 2022Article
- Implementing essential diagnostics-learning from essential medicines: A scoping review.PLOS global public health · 2022Article
- Accessibility of Essential Medicines for Children in Sichuan Province of China: A Cross-Sectional Study.Frontiers in pharmacology · 2022Article
- Article
- Health professionals' perception of pharmaceuticals procurement performance in public health facilities in Southwestern Ethiopia.Journal of pharmaceutical policy and practice · 2021Article
- Accessibility of Medicines for Children: A Systematic Review.Frontiers in pharmacology · 2021Article
- Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.PloS one · 2021Article
- Availability of essential medicines for maternal health in public health facilities of the Mwanza region, northwestern Tanzania.The journal of medicine accessArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccess to health care is a fundamental human right, and the provision of affordable, high-quality, and appropriate medicines for maternal and child health is a vital component of a well-functioning health system. The study assessed the availability, price, and affordability of WHO priority maternal and child medicines in public health facilities, Dessie, North-East Ethiopia.
methodsA retrospective cross-sectional study design was conducted in Dessie town from November 2018 to February 2019. A standard checklist adapted from the Logistics Indicator Assessment Tool and WHO/HAI was used to collecting data on the availability, affordability, and price of 45 priority life-saving medicines from eight public health centers and two public hospitals. Descriptive statistics (percent and median) were computed for availability and prices. Affordability was reported in terms of the daily wage of the lowest-paid unskilled government worker.
resultsTwenty-two medicines were not found at all in public health facilities. The overall availability of WHO priority maternal and child medicines was 34.02%. The mean number of stock-outs was 3.9, and the mean number was 128.9 days. The mean average point availability was 33.5%, and 7 medicines stock out on the days of assessment. From WHO priority maternal and child medicines, 4 (40%) of the products were unaffordable and 5 (55.5%) had higher prices than international prices. Ceftriaxone 1 g, ceftriaxone 500 mg, and hydralazine 20 mg injection required wages of 6.58, 8.01, and 5.02 to cover specific maternal health problems respectively. The median price ratio of priority lifesaving maternal and child medicines in public health facilities ranged from 0.65 to 3.19.
conclusionsThe average mean period and point mean availability was very low. The available products were encountered with a high number of stock-outs and unaffordable. The strict control of inventory is recommended to have a steady supply of these essential medicines and improve the quality of health services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.